Medinotec Past Earnings Performance
Past criteria checks 0/6
Medinotec's earnings have been declining at an average annual rate of -37.9%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 6.9% per year.
Key information
-37.9%
Earnings growth rate
-53.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -6.9% |
| Return on equity | -10.2% |
| Net Margin | -21.9% |
| Last Earnings Update | 31 May 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Medinotec makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 May 23 | 1 | 0 | 1 | 0 |
| 28 Feb 23 | 1 | 0 | 1 | 0 |
| 30 Nov 22 | 2 | 0 | 1 | 0 |
| 31 Aug 22 | 1 | 0 | 1 | 0 |
| 31 May 22 | 1 | 0 | 1 | 0 |
| 28 Feb 22 | 1 | 0 | 1 | 0 |
Quality Earnings: MDNC is currently unprofitable.
Growing Profit Margin: MDNC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if MDNC's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare MDNC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDNC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).
Return on Equity
High ROE: MDNC has a negative Return on Equity (-10.19%), as it is currently unprofitable.